
Efficacy and complications of argon plasma coagulation for hemorrhagic chronic radiation proctitis
Author(s) -
Qinghua Zhong,
Zhanzhen Liu,
Zixu Yuan,
Tenghui Ma,
Xiaoyan Huang,
Huaiming Wang,
Daici Chen,
Jianping Wang,
Lei Wang
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i13.1618
Subject(s) - medicine , argon plasma coagulation , retrospective cohort study , univariate analysis , surgery , gastroenterology , proctitis , complication , radiation therapy , radiation proctitis , multivariate analysis , disease , endoscopy , ulcerative colitis
Chronic radiation proctitis (CRP) is a complication which occurs in 1%-5% of patients who undergo radiotherapy for pelvic malignancies. Although a wide range of therapeutic modalities are available, there is no literature to date showing any particularly appropriate therapeutic modality for each disease stage. Argon plasma coagulation (APC) is currently recommended as the first-choice treatment for hemorrhagic CRP, however, its indication based on long-term follow-up is still unclear. On the hypothesis that the long-term efficacy and safety of APC are not fully understood, we reviewed APC treatment for patients with hemorrhagic CRP from a single center.